Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arizona Sci-Tech Gazette.
Press releases published on August 1, 2025
Ocugen Provides Business Update with Second Quarter 2025 Financial Results
GlobeNewswire
·
August 1, 2025
Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse …
Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys
GlobeNewswire
·
August 1, 2025
LONDON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NordVPN’s travel eSIM app Saily is launching a premium subscription plan, Saily Ultra, which offers unlimited global eSIM data combined with special benefits for travelers. “The Saily Ultra plan is designed for …
Ascentage Pharma to Participate in Evercore China Biotech Summit
GlobeNewswire
·
August 1, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Orchestra BioMed Announces Pricing of $40 Million Public Offering
GlobeNewswire
·
August 1, 2025
NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …
FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES
GlobeNewswire
·
August 1, 2025
WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, …
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
GlobeNewswire
·
August 1, 2025
SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF; OTCQB: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded …
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
GlobeNewswire
·
August 1, 2025
Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected Topline data readout anticipated this month NEW HAVEN, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI …
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
GlobeNewswire
·
August 1, 2025
Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by exceeding ORR benchmarks demonstrated …
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
GlobeNewswire
·
August 1, 2025
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, August 8, 2025, prior to the market open …
Regeneron Reports Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 1, 2025
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 22% to $4.34 billion EYLEA HD® U.S. net sales increased 29% to $393 million; total EYLEA HD and EYLEA® U.S. net …
Introducing PulpMiner: A no-code platform to convert any webpage to a real-time JSON API
GlobeNewswire
·
August 1, 2025
MUVATTUPUZHA, India, Aug. 01, 2025 (GLOBE NEWSWIRE) -- PulpMiner, an AI-powered no-code tool, is now publicly available to help users convert any webpage to a real-time JSON API. The platform removes the need for traditional, complex scraping by allowing …
Oculis Upsized Loan Facility to Access up to CHF 100 million
GlobeNewswire
·
August 1, 2025
ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet …
Atos - Half-year 2025 results on track. Full Year 2025 targets confirmed
GlobeNewswire
·
August 1, 2025
Press Release Half-year 2025 results on track Full Year 2025 targets confirmed Significant progress in the execution of the Genesis transformation plan Reset of cost base well engaged, already impacting profitability Over 50% of the overall Genesis …
Atos - Résultats semestriels 2025 conformes aux attentes. Objectifs annuels 2025 confirmés
GlobeNewswire
·
August 1, 2025
Communiqué de presse Résultats semestriels 2025 conformes aux attentes Objectifs annuels 2025 confirmés Progrès significatifs dans l'exécution du plan de transformation Genesis Ajustement bien engagé de la base de coûts, effets déjà visibles sur la …
Azerion Announces New Role for Co-Founder Atilla Aytekin
GlobeNewswire
·
August 1, 2025
Amsterdam, 1 August 2025 - Azerion today announces that, after stepping aside from his responsibilities as co-CEO in March 2023, Atilla Aytekin, Co-Founder and current member of the Management Board, has decided to transition to the position of advisor to …
Goldnx Announces Major Expansion of AI Trading Infrastructure to Support Growing Canadian Market
GlobeNewswire
·
August 1, 2025
London UK, July 31, 2025 (GLOBE NEWSWIRE) -- Goldnx reviews are generating attention across the financial sector as the company announced a major expansion of its AI-powered trading infrastructure to meet the growing demand for secure, advanced multi-asset …
Geotab Unveils Advanced Cold Chain Solution with New Hardware and Enhanced Software
GlobeNewswire
·
August 1, 2025
SYDNEY, Aug. 01, 2025 (GLOBE NEWSWIRE) -- In Australia, cold chain breakdowns are a major contributor to food loss. A 2020 government- and industry-sponsored study estimated that approximately 1.93 million tonnes of fruit and vegetables are lost in the …
Aduro Clean Technologies untersucht chemische Recyclingverfahren für Kunstrasenabfälle
GlobeNewswire
·
August 1, 2025
LONDON, Ontario, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen im Bereich sauberer Technologien, das die Kraft der Chemie nutzt, um minderwertige …